Skip to content

Genetic test can help predict who will develop hyperbilirubinaemia

Rosiglitazone improves lipoatrophy, metformin improves other forms of lipodystrophy

Efavirenz and rifampicin: UK doctors caution on higher EFV doses in Africans (corrected)

Risk of 5% weight loss increased in HAART era, not linked to lipodystrophy

Very low rate of liver problems seen with Kaletra

Risk of peripheral neuropathy five times higher for common genetic group

US men's study finds cumulative NRTI use, but not PIs or NNRTIs, associated with insulin resistance

Routine lactate monitoring warranted only in those at risk, concludes Swiss study

High proportion of HIV-positive patients obese or overweight